Development and characterization of a novel microtissue-based 3D human liver fibrosis model for anti-fibrotic drug discovery

被引：0
|
作者：
Kostadinova, R. [1 ]
Neelakandhan, A. [1 ]
Kijanska, M. [1 ]
Zapiorkowska, N. [1 ]
Steiert, S. [1 ]
Guye, P. [1 ]
Messner, S. [1 ]
机构：
[1] InSphero AG, Schlieren, Switzerland
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)30333-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PS-103
引用
收藏
页码：S56 / S56
页数：1
相关论文
共 50 条
  • [1] A novel microtissue-based 3D human liver NASH model for drug discovery
    Rupp, J.
    Strassfeld, T.
    Steiert, S.
    Guye, P.
    Messner, S.
    Kostadinova, R.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S356 - S357
  • [2] A novel microtissue-based 3D human liver NASH model for drug discovery
    Rupp, J.
    Strassfeld, T.
    Steiert, S.
    Guye, P.
    Messner, S.
    Kostadinova, R.
    TOXICOLOGY LETTERS, 2018, 295 : S79 - S79
  • [3] Development and characterization of a novel in vitro human liver fibrosis model for efficacy testing of anti-fibrotic drugs based on 3D Human Liver Microtissues
    Kostadinova, Radina
    Neelakandhan, Aparna
    Kijanska, Monika
    Zapiorkowska, Natalia
    Grepper, Sue
    Steiert, Sabrina
    Strassfeld, Tobias
    Guye, Patrick
    Messner, Simon
    HEPATOLOGY, 2017, 66 : 215A - 215A
  • [4] 3D pulmonary fibrosis model for anti-fibrotic drug discovery by inkjet-bioprinting
    Kang, Dayoon
    Lee, Yunji
    Kim, Wookyeom
    Lee, Hwa-Rim
    Jung, Sungjune
    BIOMEDICAL MATERIALS, 2023, 18 (01)
  • [5] Development of a novel human 3D in vitro model for evaluating new anti-fibrotic drugs
    Woodrooffe, A.
    Freathy, C. S.
    Maitland, S. M.
    Baggot, K. L.
    Loraine, H. J.
    Murdock, P. R.
    TOXICOLOGY LETTERS, 2019, 314 : S177 - S177
  • [6] Development of a Novel Human 3D in Vitro Model for Evaluating New Anti-Fibrotic Drugs
    Freathy, Caroline S.
    Maitland, Samantha M.
    Bagot, Kathryn L.
    Loraine, Howard J.
    Murdock, Paul R.
    Woodrooffe, Amanda
    HEPATOLOGY, 2018, 68 : 644A - 644A
  • [7] DEVELOPMENT OF A 3D SKIN MICROTISSUE MODEL FOR FIBROTIC DISEASES
    Pachera, E.
    Kania, G.
    Juengel, A.
    Calcagni, M.
    Distler, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 151 - 152
  • [8] Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac Fibrosis
    Gartner, Tom C. L. Bracco
    Deddens, Janine C.
    Mol, Emma A.
    Ferrer, Marina Magin
    van Laake, Linda W.
    Bouten, Carlijn V. C.
    Khademhosseini, Ali
    Doevendans, Pieter A.
    Suyker, Willem J. L.
    Sluijter, Joost P. G.
    Hjortnaes, Jesper
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2019, 6
  • [9] Anti-fibrotic effects of cardiac progenitor cells in a 3D-model of human cardiac fibrosis
    Gartner, T. Bracco
    Deddens, J. C.
    Mol, E. A.
    Ferrer, M. M.
    Van Laake, L. W.
    Bouten, C. V. C.
    Khademhosseini, A.
    Suyker, W. J. L.
    Sluijter, J. P. G.
    Hjortnaes, J.
    CARDIOVASCULAR RESEARCH, 2018, 114 : S37 - S37
  • [10] An in vitro osteosarcoma 3D microtissue model for drug development
    Rimann, Markus
    Laternser, Sandra
    Gvozdenovic, Ana
    Muff, Roman
    Fuchs, Bruno
    Kelm, Jens M.
    Graf-Hausner, Ursula
    JOURNAL OF BIOTECHNOLOGY, 2014, 189 : 129 - 135
12345